Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 178Lung Neoplasms 56NSCLC 11Neoplasms 10Neoplasm Metastasis 9Brain Neoplasms 8Carcinoma 7Bronchial Neoplasms 5Thoracic Neoplasms 4Colorectal Neoplasms 4Respiratory Tract Neoplasms 3Respiratory Tract Diseases 3Neoplasms by Site 3Meningeal Carcinomatosis 3Lung Diseases 3Carcinoma, Squamous Cell 3Breast Neoplasms 3Adenocarcinoma of Lung 3Adenocarcinoma 3Uterine Neoplasms 2Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Noonan Syndrome 2Non Small Cell Lung Cancer Metastatic 2Neoplasms, Nerve Tissue 2Neoplasms by Histologic Type 2Carcinoma, Bronchogenic 2Triple Negative Breast Neoplasms 1

Interventions

Platinum Compounds 2Paclitaxel 2Cisplatin 2Carboplatin 2sintilimab 1osimertinib 1cemiplimab 1Surgical Procedures, Operative 1Pemetrexed 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Resectable Non-small Cell Lung Cancer × osimertinib × Thoracic × Clear all
NCT07038460 2025-06-26

NEO-LISI

Guangdong Provincial People's Hospital

Phase 2 Not yet recruiting
134 enrolled
Thoracic

Resectable Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡